undamentalytics Newsletter
Sign in

Apyx Medical Corp income statement

In fiscal 2025, Apyx Medical Corp reported revenue of $52.8m, up 9.9% on the year before, operating income of −$6.4m (a -12.2% margin) and net income of −$11.2m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue27242528242830910172828494552485358
Cost of revenue15141516141917436910151519192021
Gross profit12101111991357111918342934293337
Research and development221111212344455533
Selling, general and administrative55446786991412192022191617
Operating income1−3−01−4−6−7−11−14−14−21−20−14−24−17−19−6−4
Interest expense———————00000002666
Net interest income−0−0−0−0−0−0−0−0−0—————————
Income before tax1−201−6−13−5−11−14−15−20−19−15−23−21−23−11−8
Income tax0−100−2400−0−4−0−800−2000
Net income1−201−4−17−5−12−563−20−12−15−23−19−23−11−9
Diluted EPS$0.03−$0.09$0.01$0.03−$0.40−$1.03$0.24−$0.15−$0.17$1.83−$0.58−$0.35−$0.44−$0.67−$0.54——−$0.20
Diluted shares (average)17m17m18m18m18m18m28m27m31m34m34m34m34m35m35m36m41m43m
EBITDA1−212−3−5−6−11−13−14−20−19−14−23−17−18−6−3

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: APYX vs LNSRAPYX vs CVRXAPT vs APYXAPYX vs IRIX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Apyx Medical Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Apyx Medical Corp.